Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTonix Pharmaceuticals Holding Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$20.00 | -$20.00 | -$20.00 |
| Q2 2025 | 1 | -$21.00 | -$21.00 | -$21.00 |
| Q3 2025 | 1 | -$23.00 | -$23.00 | -$23.00 |
| Q4 2025 | 1 | -$23.00 | -$23.00 | -$23.00 |
Tonix Pharmaceuticals Holding Corp. Earnings Date And Information
Tonix Pharmaceuticals Holding Corp. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-23 earnings per share for the quarter, topping analysts' consensus estimates of $-203 by $180. The company had revenue of 2.82 M for the quarter and had revenue of 7.77 M for the year. Tonix Pharmaceuticals Holding Corp. has generated $-219 earnings per share over the last year ($-219.09 diluted earnings per share) and currently has a price-to-earnings ratio of -6.16. Tonix Pharmaceuticals Holding Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based on prior year's report dates.
Tonix Pharmaceuticals Holding Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$203.00 | -$0.23 | 202.77 | $3.15 M | $2.82 M |
| 08/16/2024 | Q2 2024 | -$991.00 | -$19.28 | 971.72 | $3.50 M | $2.21 M |
| 05/13/2024 | Q1 2024 | N/A | -$5.91 | N/A | N/A | $2.48 M |
| 04/01/2024 | Q4 2023 | -$4,984.03 | -$27.53 | 4956.5 | N/A | $3.78 M |
| 11/09/2023 | Q3 2023 | -$4,760.38 | -$58.40 | 4701.98 | $5.80 M | $3.99 M |
| 08/10/2023 | Q2 2023 | -$8,881.79 | -$85.71 | 8796.08 | N/A | $0 |
| 05/08/2023 | Q1 2023 | -$7,987.22 | -$102.85 | 7884.37 | N/A | $33.90 M |
| 03/13/2023 | Q4 2022 | -$12,579.87 | -$111.06 | 12468.81 | N/A | $0 |
| 11/07/2022 | Q3 2022 | -$14,377.00 | -$4.24 | 14372.76 | N/A | $0 |
| 08/08/2022 | Q2 2022 | -$29,153.36 | -$244.55 | 28908.81 | N/A | $9.03 M |
| 05/09/2022 | Q1 2022 | -$31,897.85 | -$321.28 | 31576.57 | N/A | $0 |
| 03/14/2022 | Q4 2021 | -$44,656.98 | -$419.18 | 44237.8 | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$44,656.98 | -$319.96 | 44337.02 | N/A | $0 |
| 08/09/2021 | Q2 2021 | -$44,656.98 | -$449.35 | 44207.63 | N/A | $0 |
| 05/10/2021 | Q1 2021 | -$38,277.41 | -$455.62 | 37821.79 | N/A | $0 |
| 03/15/2021 | Q4 2020 | -$57,416.13 | -$664.75 | 56751.38 | N/A | $2.91 M |
| 11/09/2020 | Q3 2020 | -$70,175.26 | -$603.27 | 69571.99 | N/A | $0 |
| 08/10/2020 | Q2 2020 | -$133,971.00 | $0.00 | N/A | N/A | $0 |
| 05/12/2020 | Q1 2020 | -$312,598.90 | $0.00 | N/A | N/A | $0 |
| 03/24/2020 | Q4 2019 | -$950,555.80 | $0.00 | N/A | N/A | $-500 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tonix Pharmaceuticals Holding Corp. Earnings: FAQ's
Tonix Pharmaceuticals Holding Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based offlast year's report dates.
In the previous quarter, Tonix Pharmaceuticals Holding Corp. (:TNXP) reported $-23 earnings per share (EPS) to beat the analysts' consensus estimate of $-203 by $180.
The conference call for Tonix Pharmaceuticals Holding Corp.'s latest earnings report can be listened to online.
The conference call transcript for Tonix Pharmaceuticals Holding Corp.'s latest earnings report can be read online.
Tonix Pharmaceuticals Holding Corp. (:TNXP) has a recorded annual revenue of $7.77 M.
Tonix Pharmaceuticals Holding Corp. (:TNXP) has a recorded net income of $-116,658,000.Tonix Pharmaceuticals Holding Corp. has generated $-219.09 earnings per share over the last four quarters.
Tonix Pharmaceuticals Holding Corp. (:TNXP) has a price-to-earnings ratio of -6.16 and price/earnings-to-growth ratio is -0.12.